Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Mignani

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Biomedicines|November 25, 2023
Antipsychotics: 70 YearsGiovanni Lentini, Serge Mignani
Mini Reviews in Medicinal Chemistry|February 18, 2004
Synthesis and structure-activity relationships of 4,10-dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazine derivatives: highly potent and selective AMPA receptor antagonists with in vivo activityJean-Marie Stutzmann, Marc Vuilhorgne, Serge Mignani
Drug Discovery Today|July 9, 2016
Dendrimer-based magnetic iron oxide nanoparticles: their synthesis and biomedical applicationsWenjie Sun, Serge Mignani, Mingwu Shen, et al.
Journal of Medicinal Chemistry|July 11, 2018
Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical AnalysisSonali S Bharate, Serge Mignani, Ram A Vishwakarma
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 22, 2019
A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the marketMara Gonçalves, Serge Mignani, João Rodrigues, et al.
Future Medicinal Chemistry|May 9, 2024
Synthesis and interest in medicinal chemistry of β-phenylalanine derivatives (β-PAD): an update (2010-2022)Chloé Rémondin, Serge Mignani, Christophe Rochais, et al.
Molecular Pharmaceutics|November 25, 2020
Multivalent Copper(II)-Conjugated Phosphorus Dendrimers with Noteworthy <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activities: A Concise OverviewSerge Mignani, Xiangyang Shi, Anke Steinmetz, et al.
European Journal of Medicinal Chemistry|October 18, 2020
Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugsSerge Mignani, Xiangyang Shi, Andrii Karpus, et al.
Molecules (Basel, Switzerland)|July 2, 2021
First-in-Class Phosphorus Dendritic Framework, a Wide Surface Functional Group Palette Bringing Noteworthy Anti-Cancer and Anti-Tuberculosis Activities: What Lessons to Learn?Serge Mignani, Jérôme Bignon, Xiangyang Shi, et al.
Drug Discovery Today|April 14, 2020
Dendrimer- and polymeric nanoparticle-aptamer bioconjugates as nonviral delivery systems: a new approach in medicineSerge Mignani, Xangyang Shi, Valentin Ceña, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Biomedicines|November 25, 2023
Antipsychotics: 70 YearsGiovanni Lentini, Serge Mignani
Mini Reviews in Medicinal Chemistry|February 18, 2004
Synthesis and structure-activity relationships of 4,10-dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazine derivatives: highly potent and selective AMPA receptor antagonists with in vivo activityJean-Marie Stutzmann, Marc Vuilhorgne, Serge Mignani
Drug Discovery Today|July 9, 2016
Dendrimer-based magnetic iron oxide nanoparticles: their synthesis and biomedical applicationsWenjie Sun, Serge Mignani, Mingwu Shen, et al.
Journal of Medicinal Chemistry|July 11, 2018
Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical AnalysisSonali S Bharate, Serge Mignani, Ram A Vishwakarma
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 22, 2019
A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the marketMara Gonçalves, Serge Mignani, João Rodrigues, et al.
Future Medicinal Chemistry|May 9, 2024
Synthesis and interest in medicinal chemistry of β-phenylalanine derivatives (β-PAD): an update (2010-2022)Chloé Rémondin, Serge Mignani, Christophe Rochais, et al.
Molecular Pharmaceutics|November 25, 2020
Multivalent Copper(II)-Conjugated Phosphorus Dendrimers with Noteworthy <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activities: A Concise OverviewSerge Mignani, Xiangyang Shi, Anke Steinmetz, et al.
European Journal of Medicinal Chemistry|October 18, 2020
Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugsSerge Mignani, Xiangyang Shi, Andrii Karpus, et al.
Molecules (Basel, Switzerland)|July 2, 2021
First-in-Class Phosphorus Dendritic Framework, a Wide Surface Functional Group Palette Bringing Noteworthy Anti-Cancer and Anti-Tuberculosis Activities: What Lessons to Learn?Serge Mignani, Jérôme Bignon, Xiangyang Shi, et al.
Drug Discovery Today|April 14, 2020
Dendrimer- and polymeric nanoparticle-aptamer bioconjugates as nonviral delivery systems: a new approach in medicineSerge Mignani, Xangyang Shi, Valentin Ceña, et al.
Pageof 12